Biophytis
Paris
About Biophytis
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $45.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2025)
- Ticker: epa:ALBPS
- Website: biophytis.com
- Phone: +33 1 44 27 23 00
Industries & Categories
Biotechnology, Nutraceutical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biophytis-157650 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.